# Reduced heart rate variability predicts fatigue severity in individuals with CFS/ME

**Authors:** Escorihuela RM, Capdevila L, Castro JR, Zaragozà MC, Maurel S, Alegre J, Castro-Marrero J
**Journal:** Journal of Translational Medicine, 2020, 18(1):4
**DOI:** 10.1186/s12967-019-02184-z
**PMID:** 31906988

## Key Points

- **HRV is reduced in ME/CFS patients**: Both time-domain (RMSSD, mean RR) and frequency-domain (HF power) parameters significantly decreased compared to healthy controls
- **HRV predicts fatigue severity**: Linear regression showed significant relationships between HRV metrics (RMSSD, HFnu, mean RR) and self-reported fatigue severity
- **Autonomic dysfunction mechanism**: Results suggest increased sympathetic hyperactivity contributes to fatigue severity
- **Potential biomarker utility**: HRV parameters may serve as objective biomarkers for ME/CFS severity

## Methodology

- **Study Design:** Case-control study
- **Sample Size:** n=45 female ME/CFS patients (Fukuda criteria) + 25 age/gender-matched healthy controls
- **HRV Measurement:** Three 5-minute recordings in resting state, continuous RR interval monitoring
- **Analysis:** Time-domain (RMSSD, mean RR) and frequency-domain (HF, LF, LF/HF ratio) parameters
- **Statistical Methods:** Correlation analysis and linear regression between HRV parameters and symptom questionnaires

## Acronym Definitions

- **HRV:** Heart Rate Variability
- **RMSSD:** Root Mean Square of Successive Differences (time-domain HRV measure)
- **HF:** High Frequency power (frequency-domain HRV measure reflecting parasympathetic activity)
- **HFnu:** High Frequency normalized units
- **LF:** Low Frequency power
- **ANS:** Autonomic Nervous System
- **RR interval:** Time interval between consecutive heartbeats

## Key Findings by Metric

### Time-Domain Parameters
- **Mean RR interval:** Decreased in ME/CFS (p < 0.01), predicts fatigue (p = 0.005)
- **RMSSD:** Decreased in ME/CFS (p < 0.005), predicts fatigue (p = 0.0268)

### Frequency-Domain Parameters
- **HF power:** Decreased in ME/CFS (p < 0.005)
- **HFnu:** Predicts fatigue severity (p = 0.0067)
- **LF/HF ratio:** No significant difference (suggests balanced but suppressed autonomic tone)

## Clinical Implications

1. **Objective assessment:** HRV provides non-invasive, objective measure of autonomic dysfunction in ME/CFS
2. **Severity stratification:** HRV parameters correlate with symptom severity, potentially useful for tracking disease progression
3. **Treatment target:** Interventions that improve HRV (parasympathetic activation) may reduce fatigue severity
4. **Activity guidance:** Low HRV may indicate reduced capacity for exertion, supporting HRV-guided pacing approaches

## Limitations

- **Female-only sample:** All participants were female; generalizability to males unclear
- **Cross-sectional design:** Cannot establish causality (does low HRV cause fatigue, or vice versa?)
- **Single time point:** 5-minute recordings may not capture circadian variation or day-to-day variability
- **No longitudinal tracking:** Unable to assess whether HRV changes predict symptom changes over time

## Certainty Assessment

- **Study Quality:** Medium-High (well-designed case-control, validated methods)
- **Sample Size:** n=45 (adequate for correlation analysis, modest for regression)
- **Replication:** Consistent with prior smaller studies; needs replication in larger cohorts
- **Conflicts of Interest:** None declared
- **Generalizability:** Female-only, Fukuda criteria (may not apply to all ME/CFS phenotypes)

## Integration Points

### Chapter 8: Neurological Pathophysiology (ch08-neurological.tex)
- **Section:** Autonomic dysfunction
- **Citation type:** Achievement (established finding)
- **Key point:** HRV reduction predicts fatigue severity, supporting sympathetic hyperactivity hypothesis

### Chapter 14b: Mild-Moderate Treatment (ch14b-action-mild-moderate.tex)
- **Section:** HRV-Guided Activity Management protocol
- **Citation type:** Achievement (empirical evidence)
- **Key point:** Establishes HRV-fatigue relationship justifying use of HRV for activity guidance

### Chapter 10: Cardiovascular Pathophysiology (ch10-cardiovascular.tex)
- **Section:** Autonomic dysfunction and orthostatic intolerance
- **Citation type:** Observation (clinical finding)
- **Key point:** Links reduced HRV to cardiovascular manifestations in ME/CFS

## Recommended BibTeX Entry

```bibtex
@article{Escorihuela2020hrv,
  author = {Escorihuela, Rosa Maria and Capdevila, Lluis and Castro, Jose R. and Zaragozà, M. Carmen and Maurel, Sílvia and Alegre, José and Castro-Marrero, Jesus},
  title = {Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis},
  journal = {Journal of Translational Medicine},
  year = {2020},
  volume = {18},
  number = {1},
  pages = {4},
  doi = {10.1186/s12967-019-02184-z},
  pmid = {31906988},
  pmcid = {PMC6943898},
  keywords = {ME/CFS, HRV, heart rate variability, autonomic dysfunction, fatigue, biomarker}
}
```
